Huahai Pharmaceuticals hydrochloride sheet obtained the U.S. FDA approval number.
-
Last Update: 2020-07-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Guide: The acetate tablets are mainly used to treat minor brain dysfunction attention deficit disorder (child hyperactivity syndrome) and so on.!----, Zhejiang Huahai Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received a notice from the U.S. Food and Drug Administration, the company to the U.S. FDA to declare a new drug application for the acetate (ANDA, i.e., U.S. generic sorcation, application for FDA review approval means that the applicant can produce and market the product in the U.S.) has been approved.hydrochloride tablets are mainly used to treat minor brain dysfunction attention deficit disorder (hyperactivity syndrome in children) and so on.hydrochloride sheet was developed by Novartis and first listed in the United States in 1975.at present, in the United States, the main manufacturers of acetate tablets are CamberPharm, Mallinckrodt, etc. ;.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
